MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$226,651K
Marketable securities
$90,328K
Prepaid expenses and
other current assets
$6,604K
Accounts receivable, net
$88K
Total property and
equipment
$1,864K
Total current assets
$323,671K
Operating lease
right-of-use assets
$5,181K
Deposits and other assets
$2,498K
Restricted cash
equivalents
$985K
Property and equipment,
net
$310K
Less accumulated
depreciation
$1,554K
Total assets
$332,645K
Total liabilities and
stockholders' equity
$332,645K
Total stockholders'
equity
$305,259K
Total liabilities
$27,386K
Accumulated deficit
-$751,427K
Additional paid-in capital
$1,056,271K
Total current
liabilities
$22,688K
Operating lease
liabilities, net of current...
$4,698K
Accumulated other
comprehensive income (loss)
$404K
Common stock, 0.0001
par value...
$11K
Accrued expenses
$17,910K
Accounts payable
$3,519K
Operating lease
liabilities, current portion
$1,259K
Back
Back
Balance Sheet
source: myfinsight.com
Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. (AMLX)